Effect of gonadectomy on discriminative stimulus effects of morphine in female versus male rats

Drug and Alcohol Dependence

Volumn 53, Issue 2, 1999, Pages 95-109

  Craft, Rebecca M ^a   Heideman, Leah M ^a   Bartok, Rory E ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Drug discrimination; Gonadectomy; Hormones; Morphine; Opioids; Sex differences

Indexed keywords

BUPRENORPHINE; FENTANYL; MORPHINE; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALBUPHINE; NALTREXONE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; FEMALE; GONADECTOMY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BUPRENORPHINE; CASTRATION; DISCRIMINATION LEARNING; FEMALE; FENTANYL; GONADAL STEROID HORMONES; INJECTIONS; MALE; MORPHINE; NALBUPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NOCICEPTORS; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

EID: 0032889791     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00112-4     Document Type: Article

References (58)

1. Anthony, J.C., Helzer, J.E., 1991. Syndromes of drug abuse and dependence. In: Robins, L.N., Regier, D.A. (Eds.), Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. The Free Press, New York, pp. 116-154.
2. Baamonde A.I., Hidalgo A., Andres-Trelles F. Sex-related differences in the effects of morphine and stress on visceral pain. Neuropharmacology. 28:1989;967-970.
3. Becker J.B., Robinson T.E., Lorenz K.A. Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. Eur. J. Pharmacol. 80:1982;65-72.
4. Candido J., Lutfy K., Billings B., Sierra V., Duttaroy A., Inturrisi C.E., Yoburn B.C. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharmacol. Biochem. Behav. 42:1992;685-692.
5. Chait L.D. Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology. 113:1994;381-387.
6. Chait L.D., Uhlenhuth E.H., Johanson C.-E. Individual differences in the discriminative stimulus effects of d-amphetamine in humans. Drug Dev. Res. 16:1989;451-460.
7. Chen J.-C., Smith E.R., Cahill M., Cohen R., Fishman J.B. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sci. 52:1992;389-396.
8. Cicero T.J., Newman K.S., Meyer E.R. Testosterone does not influence opiate binding sites in the male rat brain. Life Sci. 33:1983;1231-1239.
9. Cicero T.J., Nock B., Meyer E.R. Gender-related differences in the antinociceptive properties of morphine. J. Pharmacol. Exp. Ther. 279:1996;767-773.
10. Cicero T.J., Nock B., Meyer E.R. Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations. J. Pharmacol. Exp. Ther. 282:1997;939-944.
11. Comer S.D., McNutt R.W., Chang K.-J., De Costa B.R., Mosberg H.I., Woods J.H. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors. J. Pharmacol. Exp. Ther. 267:1993;866-874.
12. Craft R.M., Stratmann J.A. Discriminative stimulus properties of cocaine in female versus male rats. Drug Alcohol Depend. 42:1996;27-37.
13. Craft R.M., Kalivas P.W., Stratmann J.A. Sex differences in discriminative stimulus effects of morphine in the rat. Behav. Pharmacol. 7:1996;764-778.
14. Craft, R.M., Kruzich, P.J., Boyer, J.S., Harding, J.W., Hanesworth, J.M., in press. Sex differences in discriminative stimulus and diuretic effects of the κ opioid agonist U69,593 in the rat. Pharmacol. Biochem. Behav.
15. Craft, R.M., Morgan, C.L., Bernal, S.A., in press. Reinforcement frequency but not gender determines sensitivity to the discriminative stimulus effects of morphine. Behav. Pharmacol.
16. De Vry J., Koek W., Slangen J.L. Effects of drug-induced differences in reinforcement frequency on discriminative stimulus properties of fentanyl. Psychopharmacology. 83:1984;257-261.
17. deSouza E.B., Schmidt W.K., Kuhar M.J. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. J. Pharmacol. Exp. Ther. 244:1988;391-402.
18. deWit H., Rukstalis M. Acute effects of triazolam in women: relationships with progesterone, estradiol and allopregnanolone. Psychopharmacology. 130:1997;69-78.
19. Diaz-Veliz G., Baeza R., Benavente F., Dussaubat N., Mora S. Influence of the estrous cycle and estradiol on the behavioral effects of amphetamine and apomorphine in rats. Pharmacol. Biochem. Behav. 49:1994;819-825.
20. 6 glioma cell line expressing the μ opioid receptor. J. Pharmacol. Exp. Ther. 278:1996;1121-1127.
21. Forgie M.L., Stewart J. Sex differences in the locomotor-activating effects of amphetamine: role of circulating testosterone in adulthood. Physiol. Behav. 55:1994;639-644.
22. Freeman, M.E., 1988. The ovarian cycle in the rat. In: Knobil, E., Neill, J. (Eds.), The Physiology of Reproduction. Raven Press, New York, pp. 1893-1928.
23. Gordon F.T., Soliman M.R.I. The effects of estradiol and progesterone on pain sensitivity and brain opioid receptors in ovariectomized rats. Horm. Behav. 30:1996;244-250.
24. Grant K.A., Azarov A., Shively C.A., Purdy R.H. Discriminative stimulus effects of ethanol and 3α-hydroxy-5α-prenan-20-one in relation to menstrual cycle phase in cynomolgus monkeys (Macaca fascicularis). Psychopharmacology. 130:1997;59-68.
25. Hahn E.F., Fishman J. Castration affects male rat brain opiate receptor content. Neuroendocrinology. 41:1985;60-63.
26. Hammer R.P. μ-Opiate receptor binding in the medial preoptic area is cyclical and sexually dimorphic. Brain Res. 515:1990;187-192.
27. Islam A.K., Cooper M.L., Bodnar R.J. Interactions among aging, gender, and gonadectomy effects upon morphine antinociception in rats. Physiol. Behav. 54:1993;45-53.
28. Janik J., Callahan P., Rabii J. Morphine induced analgesia is attenuated in post-partum lactating rats. Life Sci. 52:1993;271-279.
29. Jasinski, D.R., Henningfield, J.E., 1989. Human abuse liability assessment by measurement of subjective and physiological effects. In: Fischman, M.W., Mello, N.K. (Eds.), Testing for Abuse Liability of Drugs in Humans. NIDA Research Monograph 92, U.S. Government Printing Office, Washington, DC.
30. Johnston, L.D., O'Malley, P.M., Bachman, J.G., 1994a. National Survey Results on Drug Use from the Monitoring the Future Study, 1975-1993, vol. I. NIH Publication No. 94-3809, p. 55.
31. Johnston, L.D., O'Malley, P.M., Bachman, J.G., 1994b. National Survey Results on Drug use from the Monitoring the Future Study, 1975-1993, vol. II. NIH Publication No. 94-3810, p. 153.
32. Joyce E.M., Iverson S.D. The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neurosci. Lett. 14:1979;207-212.
33. Kalivas P.W., Duffy P. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J. Pharmacol. Exp. Ther. 241:1987;204-212.
34. Kelleher, R.T., Morse, W.H., 1969. Determinants of the behavioral effects of drugs. In: Tedeschi, D.H., Tedeschi, R.E. (Eds.), Importance of Fundamental Principles in Drug Evaluation. Raven Press, New York, pp. 383-405.
35. Kepler K.L., Kest B., Kiefel J.M., Cooper M.L., Bodnar R.J. Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol. Biochem. Behav. 34:1989;119-127.
36. 3H]U-69593: a highly selective ligand for the opioid κ receptor. Eur. J. Pharmacol. 109:1985;281-284.
37. Le S., Chuong C.J., Parkening T.A. Effect of ovariectomy and estrogen replacement on hypothalamic, pituitary and peripheral blood β-endorphin levels in the rat. Neuropeptides. 20:1991;175-180.
38. Lukas S.E., Sholar M., Lundahl L.H., Lamas X., Kouri E., Wines J.D., Kragie L., Mendelson J.H. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology. 125:1996;346-354.
39. McMillan D.E., Morse W.H. Some effects of morphine and morphine antagonists on schedule-controlled behavior. J. Pharmacol. Exp. Ther. 157:1967;175-184.
40. Morgan D., Picker M.J. Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: importance of the drug's relative intrinsic efficacy at the μ receptor. Behav. Pharmacol. 6:1996;261-275.
41. Negus S.S., Picker M.J., Dykstra L.A. Interactions between μ and κ opioid agonists in the rat drug discrimination procedure. Psychopharmacology. 102:1990;465-473.
42. NIDA 1993 National Household Survey on Drug Abuse: Preliminary estimates 1993, DHHS Advance Report No. 7, US Government Printing Office, Washington, DC, July 1994.
43. Paronis C.A., Holtzman S.G. Sensitization and tolerance to the discriminative stimulus effects of μ-opioid agonists. Psychopharmacology. 114:1994;601-610.
44. Perkins K.A., DiMarco A., Grobe J.E., Scierka A., Stiller R.L. Nicotine discrimination in male and female smokers. Psychopharmacology. 116:1994;407-413.
45. Picker M.J., Doty P., Negus S.S., Mattox S.R., Dykstra L.A. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by μ and κ opioid agonists. J. Pharmacol. Exp. Ther. 254:1990;13-22.
46. Picker M.J., Yarbrough J., Hughes C.E., Smith M.A., Morgan D., Dykstra L.A. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences. J. Pharmacol. Exp. Ther. 266:1993;756-767.
47. Ratka A., Simpkins J.W. A modulatory role for luteinizing hormone-releasing hormone in nociceptive responses of female rats. Endocrinology. 127:1990;667-673.
48. Roberts D.C.S., Bennett S.A.L., Vickers G.J. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology. 98:1989;408-411.
49. Savageau M.M., Beatty W.W. Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats. Pharmacol. Biochem. Behav. 14:1981;17-21.
50. Schaeffer G.J., Holtzman S.G. Discriminative effects of morphine in the squirrel monkey. J. Pharmacol. Exp. Ther. 201:1977;67-75.
51. Shannon H.E., Holtzman S.G. Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology. 61:1979;239-244.
52. Simerly R.B., McCall L.D., Watson S.J. Distribution of opioid peptides in the preoptic region: Immunohistochemical evidence for a steroid-sensitive enkephalin sexual dimorphism. J. Comp. Neurol. 276:1988;442-459.
53. Smith, E.R., Damassa, D.A., Davidson, J.M., 1977. Hormone administration: peripheral and intracranial implants. In: Myers, R.D. (Ed.), Methods in Psychobiology, vol. 3. Academic Press, New York, pp. 259-279.
54. Tallarida, R.J., Murray, R.B., 1987. Manual of Pharmacologic Calculations with Computer Programs, 2nd ed. Springer-Verlag, New York.
55. van Haaren F., Meyer M.E. Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacol. Biochem. Behav. 39:1991;923-927.
56. Vanacek S.A., Young A.M. Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons. Behav. Pharmacol. 6:1995;669-681.
57. 2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. J. Pharmacol. Exp. Ther. 271:1994;959-968.
58. Young A.M., Masaki M.A., Geula C. Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of μ opioids. J. Pharmacol. Exp. Ther. 261:1992;246-257.